EZH2-Mediated microRNA-375 Upregulation Promotes Progression of Breast Cancer via the Inhibition of FOXO1 and the p53 Signaling Pathway
出版年份 2021 全文链接
标题
EZH2-Mediated microRNA-375 Upregulation Promotes Progression of Breast Cancer via the Inhibition of FOXO1 and the p53 Signaling Pathway
作者
关键词
-
出版物
Frontiers in Genetics
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-30
DOI
10.3389/fgene.2021.633756
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression
- (2020) Ying-rui Shi et al. Frontiers in Pharmacology
- Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
- (2020) Xueliang Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
- (2019) Ying Ying Su et al. Journal of Ovarian Research
- CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression
- (2019) Yichong Ning et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer
- (2019) Jiaxuan Liu et al. JOURNAL OF APPLIED GENETICS
- Up-regulated ADP-Ribosylation factor 3 promotes breast cancer cell proliferation through the participation of FOXO1
- (2019) Danping Huang et al. EXPERIMENTAL CELL RESEARCH
- The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study
- (2019) Wei Tang et al. PATHOLOGY RESEARCH AND PRACTICE
- MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
- (2019) Mohammad Mijanur Rahman et al. Cells
- Targeting FGFR pathway in breast cancer
- (2018) J. Perez-Garcia et al. BREAST
- Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
- (2018) Michael J. Duffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
- (2018) Jacopo Sgrignani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells
- (2018) Lu Han et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Emerging microRNAs in cancer diagnosis, progression, and immune surveillance
- (2018) Amani M. Harrandah et al. CANCER LETTERS
- Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF‐κB and p53
- (2018) Yan Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
- (2017) Ke-Sin Yan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
- (2017) Jing Tian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses
- (2017) Lin Shi et al. PATHOLOGY RESEARCH AND PRACTICE
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers
- (2016) Ching-Yu Yen et al. CANCER LETTERS
- Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells
- (2016) Pan Yu et al. CELL BIOLOGY INTERNATIONAL
- Lateral Thinking: How Histone Modifications Regulate Gene Expression
- (2016) Moyra Lawrence et al. TRENDS IN GENETICS
- DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression
- (2015) Xianghong Ning et al. CANCER LETTERS
- FOXO transcription factors in cancer development and therapy
- (2015) Alexandra Coomans de Brachène et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
- (2012) Alexander H Stegh EXPERT OPINION ON THERAPEUTIC TARGETS
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now